This page includes the latest FDA filings for Astrazeneca Nijmegen B V. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
Device Company | Device | Date |
|---|---|---|
| Swedish Orphan Biovitrum AB (publ), Almac Pharma Services LLC, AstraZeneca Nijmegen B.V., AstraZeneca Pharmaceuticals LP, BioReliance Corporation, Boehringer Ingelheim Pharma GmbH and Co., Charles River Laboratories, Inc., Eurofins Lancaster Laboratories, Inc. | Prescription Medication | 2022-03-29 |
| Swedish Orphan Biovitrum AB (publ), Almac Pharma Services LLC, AstraZeneca Nijmegen B.V., AstraZeneca Pharmaceuticals LP, BioReliance Corporation, Boehringer Ingelheim Pharma GmbH and Co., Charles River Laboratories, Inc., Eurofins Lancaster Laboratories, Inc. | Prescription Medication | 2021-09-29 |
| Swedish Orphan Biovitrum AB (publ), Almac Pharma Services LLC, AstraZeneca Nijmegen B.V., AstraZeneca Pharmaceuticals LP, BioReliance Corporation, Boehringer Ingelheim Pharma GmbH and Co., Charles River Laboratories, Inc., Eurofins Lancaster Laboratories, Inc. | Prescription Medication | 2020-12-02 |